ArticleJapanese journal of clinical oncology2024

Evaluation of PET/CT imaging with [89Zr]Zr-DFO-girentuximab: a phase 1 clinical study in Japanese patients with renal cell carcinoma (Zirdac-JP).

Noboru Nakaigawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.